<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Locatelli D</submitter><funding>Telethon</funding><pagination>25782-94</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC3406665</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>287(31)</volume><pubmed_abstract>Spinal muscular atrophy is a fatal genetic disease of motoneurons due to loss of full-length survival of motor neuron protein, the main product of the disease gene SMN1. Axonal SMN (a-SMN) is an alternatively spliced isoform of SMN1, generated by retention of intron 3. To study a-SMN function, we generated cellular clones for the expression of the protein in mouse motoneuron-like NSC34 cells. The model was instrumental in providing evidence that a-SMN decreases cell growth and plays an important role in the processes of axon growth and cellular motility. In our conditions, low levels of a-SMN expression were sufficient to trigger the observed biological effects, which were not modified by further increasing the amounts of the expressed protein. Differential transcriptome analysis led to th</pubmed_abstract><journal>The Journal of biological chemistry</journal><pubmed_title>Human axonal survival of motor neuron (a-SMN) protein stimulates axon growth, cell motility, C-C motif ligand 2 (CCL2), and insulin-like growth factor-1 (IGF1) production.</pubmed_title><pmcid>PMC3406665</pmcid><funding_grant_id>GGP07223</funding_grant_id><pubmed_authors>Fratelli M</pubmed_authors><pubmed_authors>Barzago MM</pubmed_authors><pubmed_authors>Capra S</pubmed_authors><pubmed_authors>Terao M</pubmed_authors><pubmed_authors>D'Errico P</pubmed_authors><pubmed_authors>Kurosaki M</pubmed_authors><pubmed_authors>Lupi M</pubmed_authors><pubmed_authors>Zanetti A</pubmed_authors><pubmed_authors>Uggetti A</pubmed_authors><pubmed_authors>Battaglia GS</pubmed_authors><pubmed_authors>Locatelli D</pubmed_authors><pubmed_authors>Garattini E</pubmed_authors></additional><is_claimable>false</is_claimable><name>Human axonal survival of motor neuron (a-SMN) protein stimulates axon growth, cell motility, C-C motif ligand 2 (CCL2), and insulin-like growth factor-1 (IGF1) production.</name><description>Spinal muscular atrophy is a fatal genetic disease of motoneurons due to loss of full-length survival of motor neuron protein, the main product of the disease gene SMN1. Axonal SMN (a-SMN) is an alternatively spliced isoform of SMN1, generated by retention of intron 3. To study a-SMN function, we generated cellular clones for the expression of the protein in mouse motoneuron-like NSC34 cells. The model was instrumental in providing evidence that a-SMN decreases cell growth and plays an important role in the processes of axon growth and cellular motility. In our conditions, low levels of a-SMN expression were sufficient to trigger the observed biological effects, which were not modified by further increasing the amounts of the expressed protein. Differential transcriptome analysis led to th</description><dates><release>2012-01-01T00:00:00Z</release><publication>2012 Jul</publication><modification>2025-04-04T23:29:25.877Z</modification><creation>2019-06-05T17:28:51Z</creation></dates><accession>S-EPMC3406665</accession><cross_references><pubmed>22669976</pubmed><doi>10.1074/jbc.M112.362830</doi></cross_references></HashMap>